Cullinan Therapeutics, Inc. (CGEM) stock
Close on Nov 12, 2026Market cap $655.77MP/E –Yield –
Cullinan Therapeutics statistics
58 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Mar 9, 2027 (estimated, before the open)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
Share statisticsIndustry
- Shares Change (QoQ)
- 0.86%
- 0.48%
- Float
- 57M
- 49M
- Shares Held by Insiders
- 10.9%
- 12.1%
- Shares Held by Institutions
- 111.4%
- 56.4%
Short sellingIndustry
- Short Interest
- 8M
- –
- Short Interest Change
- 3.78%
- -0.76%
- Short % of Float
- 13.8%
- 9.06%
- Short % of Shares Outstanding
- 12.3%
- 6.30%
- Days to Cover
- 13.33
- 5.13
Stock price statisticsIndustry
- 52-Week High
- $23.19
- –
- 52-Week Low
- $7.72
- –
- 20-Day Moving Average
- $13.56
- –
- 50-Day Moving Average
- $16.11
- –
- 200-Day Moving Average
- $15.83
- –
- Average True Range (14)
- $1.20
- –
- Price Change (1 Week)
- -5.65%
- 1.51%
- Price Change (1 Month)
- -25.3%
- -2.37%
- Price Change (3 Months)
- -49.9%
- -21.1%
- Price Change (6 Months)
- -36.9%
- -22.8%
- Price Change (YTD)
- -1.55%
- -22.6%
- Price Change (1 Year)
- 30.6%
- -21.0%
- Price Change (3 Years)
- 16.2%
- -24.8%
- Price Change (5 Years)
- -51.9%
- -76.9%
- Average Volume (10 Days)
- 1M
- –
- Average Volume (20 Days)
- 842,698
- –
- Average Volume (90 Days)
- 857,266
- –
- Relative Volume
- 1.33
- 0.80
- Relative Strength Index (14)
- 29.9
- 44.7
- Volatility (1 Year)
- 82.5%
- 80.2%
- Beta (5 Years)
- 0.86
- 1.07
Returns on capitalIndustry
- Return on Equity (ROE)
- -48.7%
- -51.3%
- Return on Assets (ROA)
- -54.5%
- -40.7%
- Return on Invested Capital (ROIC)
- -160.7%
- -32.9%
- Return on Capital Employed (ROCE)
- -85.6%
- -38.1%
Financial positionIndustry
- Current Ratio
- 7.43
- 3.31
- Quick Ratio
- 7.22
- 2.41
EfficiencyIndustry
- Profits Per Employee
- -$2.02M
- -$683.67K
- Employee Count
- 109
- 75
- WACC
- 9.16%
- 10.0%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $289.60M
- $16.98M
- Net Cash Per Share
- $4.50
- $0.72
- Working Capital
- $258.02M
- $78.52M
Cash flow (TTM)Industry
- Capital Expenditures
- -$49.00K
- -$944.00K
- FCF Per Share
- -$2.73
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -33.5%
- -21.0%
- FCF Yield
- -26.8%
- -9.44%
- Buyback Yield
- 0.00%
- -0.73%
- Shareholder Yield
- 0.00%
- 0.00%
Scores and fair valueIndustry
- Altman Z-Score
- 4.80
- 0.26
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | CGEM | S&P 500 | Difference | CGEM per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -31.8% | -2.7% | −29.1 pts | ||
| 3 months | -48.0% | -1.7% | −46.3 pts | ||
| Year to date | -1.5% | +11.9% | −13.4 pts | ||
| 1 year | +22.0% | +12.0% | +10.1 pts | ||
| 3 years | +12.1% | +78.2% | −66.1 pts | +3.9% | +21.2% |
| 5 years | -51.9% | +73.2% | −125.1 pts | -13.6% | +11.6% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
8M CGEM shares were sold short on Oct 30, 2026, up 3.8% from the previous report, or 13.83% of the shares available to trade. At recent volumes it would take 13.3 days to buy them back. Over the last 20 sessions, 67.6% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 7,928,668 | +3.8% | 594,711 | 13.3 |
| Oct 15, 2026 | 7,640,003 | +0.1% | 930,539 | 8.2 |
| Sep 30, 2026 | 7,634,127 | -20.7% | 1,505,393 | 5.1 |
| Sep 15, 2026 | 9,629,017 | -7.2% | 884,954 | 10.9 |
| Aug 31, 2026 | 10,371,763 | -2.0% | 669,836 | 15.5 |
| Aug 14, 2026 | 10,588,430 | +3.3% | 685,400 | 15.4 |
| Jul 31, 2026 | 10,254,541 | -0.3% | 534,845 | 19.2 |
| Jul 15, 2026 | 10,285,963 | -2.9% | 675,823 | 15.2 |
| Jun 30, 2026 | 10,597,500 | +29.5% | 1,600,967 | 6.6 |
| Jun 15, 2026 | 8,185,218 | +2.7% | 1,301,502 | 6.3 |
| May 29, 2026 | 7,973,648 | -8.1% | 1,130,798 | 7.0 |
| May 15, 2026 | 8,680,186 | -1.4% | 1,060,154 | 8.2 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?